Drug-induced nightmares

Annals of Pharmacotherapy

Volumn 33, Issue 1, 1999, Pages 93-98

  Thompson, Dennis F ^a   Pierce, Dana Reid ^b  

^a SOUTHWESTERN OKLAHOMA STATE UNIVERSITY   (United States)

^b NONE

Author keywords

blockers; Adverse reactions; Amphetamines; Sedative hypnotics

Indexed keywords

15 DEOXYSPERGUALIN; AMANTADINE; AMPHETAMINE; AMPHETAMINE DERIVATIVE; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETANIDINE; BISOPROLOL; CABERGOLINE; CARBACHOL; DIGOXIN; DOPAMINE RECEPTOR STIMULATING AGENT; ERYTHROMYCIN; FENFLURAMINE; FLEROXACIN; FLUNITRAZEPAM; GUANETHIDINE; HYPNOTIC SEDATIVE AGENT; LABETALOL; LEVODOPA; OXPRENOLOL; PHENMETRAZINE; PROPANOL; RITANSERIN; TRAMADOL; TRIAZOLAM; UNINDEXED DRUG; VERAPAMIL; ZOPICLONE;

ANXIETY; CLINICAL RESEARCH; DATA BASE; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; FEAR; HUMAN; MEDICAL INFORMATION; NIGHTMARE; PRIORITY JOURNAL; REM SLEEP; REVIEW;

ADRENERGIC BETA-ANTAGONISTS; AMPHETAMINES; DREAMS; HUMANS; HYPNOTICS AND SEDATIVES; MEDLINE; SLEEP DISORDERS; SLEEP, REM;

EID: 0032927747     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.18150     Document Type: Review

References (72)

1. Kales A, Solclatos CR, Caldwell AB, Charney DS, Kales JD, Markel D, et al. Nightmares: clinical characteristics and personality patterns. Am J Psychiatry 1980:137:1197-201.
2. Pagel JF. Nightmares. Am Fam Physician 1989:39:145-8.
3. Kales A, Soldatos CR, Kales JD. Taking a sleep history. Am Fam Physician 1980;22:101-7.
4. Kales A, Soldatos CR, Kales JD. Sleep disorders: insomnia, sleepwalking, night terrors, nightmares, and enuresis. Ann Intern Med 1987;106: 582-92.
5. Diagnostic Classification Steering Committee. International Classification of Sleep Disorders: diagnostic and coding manual. Rochester, MN: American Sleep Disorders Association, 1990:15-7.
6. Murray JB. Psychophysiological aspects of nightmares, night terrors, and sleepwalking. J Gen Psychol 1991;118:113-27.
7. Hobson JA. Sleep and dreaming. J Neurosci 1990;10:371-82.
8. Claridge G, Clark K, Davis C. Nightmares, dreams, and schizotypy. Br J Clin Psychol 1997;36:377-86.
9. Hobson JA. Dreaming as delirium: a mental status analysis of our nightly madness. Semin Neurol 1997;17:121-8.
10. Leung AK, Robson WL. Nightmares. J Natl Med Assoc 1993;85:233-5.
11. Erman MK. Dream anxiety attacks (nightmares). Psychiatr Clin North Am 1987;10:667-74.
12. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
13. Michel DJ, Knodel LC. Comparison of three algorithms used to evaluate adverse drug reactions. Am J Hosp Pharm 1986;43:1709-14.
14. Busto U, Naranjo CA, Sellers EM. Comparison of two recently published algorithms to assess the probability of adverse drug reactions (abstract). Clin Pharmacol Ther 1981;29:236.
15. Hartmann E. Pharmacological studies of sleep and dreaming: chemical and clinical relationships. Biol Psychiatry 1969;1:243-58.
16. Ornstein PH, Whitman RM, Kramer M, Baldridge BJ. Drugs and dreams IV: tranquilizers and their effects upon dreams and dreaming in schizophrenic patients. Exp Med Surg 1969;27:145-56.
17. Whitman RM, Kramer M, Ornstein PH, Baldridge BJ. Drugs and dream content. Exp Med Surg 1969;27:210-23.
18. Novak M, Shapiro CM. Drug induced sleep disturbances: focus on non-psychotropic medications. Drug Saf 1997;16:133-49.
19. Kohli RS, Khurmi NS, Kardash MM, Hughes LO, Lahiri A, Raftery EB. Efficacy of once daily bisoprolol in stable angina pectoris: an objective comparison with atenolol and long term follow-up. Eur Heart J 1985;6: 845-50.
20. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Multiclinic controlled trial of bethanidine and guanethidine in severe hypertension. Circulation 1977;55:519-25.
21. Weiner L, Frithz G. Dose-effect relationship and long-term effects of bisoprolol in mild to moderate hypertension. J Cardiovasc Pharmacol 1986;8(suppl 11):S106-12.
22. Webster J, Piscitelli G, Polli A, D'Alberton A, Falsetti L, Ferrari C, et al. Dose-dependent suppression of serum prolactin by cabergoline in hyperprolactinaemia: a placebo controlled, double-blind, multicentre study. Clin Endocrinol (Oxf) 1992;37:534-41.
23. Hadler AJ. Weight reduction with phenmetrazine and chlorphentermine: a double-blind study. Curr Ther Res 1967;9:563-9.
24. Mullen A, Wilson CWM, Wilson BPM. Dreaming, fenfluramine and vitamin C. Br Med J 1977;1:70-2.
25. Mullen A, Wilson CWM. Fenfluramine and dreaming (letter). Lancet 1974;9:594.
26. Bowie WR, Willetts V, Jewesson PJ. Adverse reactions in a dose-ranging study with a new long-acting fluoroquinolone, fleroxacin. Antimicrob Agents Chemother 1989;33:1778-82.
27. Fisher RJH, Dean BC. A multi-centre, double-blind trial in general practice comparing the hypnotic efficacy and event profiles of flunitrazepam and temazepam. Pharmatherapeutica 1985;4:231-5.
28. Ohlman S, Gannedahl G, Tyden G, Tufveson G, Groth CG. Treatment of renal transplant rejection with 15-deoxyspergualin - a dose-finding study in man. Transplant Proc 1992;24:318-20.
29. Hansson L, Hanel B. Antihypertensive effect of labetalol, a new alpha- and beta-adrenergic blocking agent. Int J Clin Pharm 1976;14:195-8.
30. Waal-Manning HJ, Simpson FO. Review of long-term treatment with labetalol. Br J Clin Pharmacol 1982;13(suppl):65s-73s.
31. Miller EM, Nieburg HA. L-tryptophan in the treatment of levodopa-induced psychiatric disorders. Dis Nerv Sys 1974;35:20-3.
32. Veterans Administration Cooperative Study Group. Oxprenolol vs propranolol: a randomized, double-blind, multiclinic trial in hypertensive patients taking hydrochlorothiazide. Hypertension 1981;3:250-6.
33. 2-receptor blockade by ritanserin does not reduce blood pressure in patients with essential hypertension. Acta Med Scand 1987;222:307-10.
34. Venter CP, Joubert PH, Stahmer SD, Venter MR, Sharkey J. Zopiclone compared with triazolam in insomnia in geriatric patients. Curr Ther Res 1986;40:1062-8.
35. Ansoms S, Lebon O, Pelc I, Cabri C, Poels R. Zopiclone or lormetazepam in the treatment of insomnia and the effect on behavior and mood in patients during the postalcoholism withdrawal period. Curr Ther Res 1991;49:54-64.
36. Van Moffaert M, Wilmotte J, Mesters P, Van Wettere JP, Cabri C, Poels R. Comparison of zopiclone and flunitrazepam in the treatment of insomnia in depressed patients. Curr Ther Res 1990;48:140-53.
37. Ing TS, Rahn AC, Armbruster KFW, Oyama JH, Klawans HL. Accumulation of amantadine hydrochloride in renal insufficiency (letter). N Engl J Med 1974;291:1257.
38. Mort JR. Nightmare cessation following alteration of ophthalmic administration of a cholinergic and a beta-blocking agent. Ann Pharmacother 1992;26:914-6.
39. Kuriyama S. Bisoprolol-induced nightmares (letter). J Hum Hypertens 1994;8:731.
40. MacEvilly M, O'Carroll C. Hallucinations after epidural buprenorphine. Br Med J 1989;298:928-9.
41. Balon R. Bupropion and nightmares (letter). Am J Psychiatry 1996;153: 579-80.
42. Haffner CA, Smith BS, Pepper C. Hallucinations as an adverse effect of angiotensin converting enzyme inhibition (letter). Postgrad Med J 1993; 69:240.
43. DeHart C. Adverse behavioral effects as manifestations of the major and minor tranquilizers. J Maine Med Assoc 1969;60:29-31.
44. Dey SK. Nightmare due to ciprofloxacin in young patient. Indian Ped 1995;32:918-20.
45. Brezis M, Michaeli J, Hamburger R. Nightmares from digoxin (letter). Ann Intern Med 1980;93:639-40.
46. Ross JS, Shua-Haim JR. Aricept-induced nightmares in Alzheimer's disease: 2 case reports. J Am Geriatr Soc 1998;46:119-20.
47. Black RJ, Dawson TAJ. Erythromycin and nightmares (letter). BMJ 1988;296:1070.
48. Williams NR. Erythromycin: a case of nightmares (letter). BMJ 1988; 296:4.
49. Alvi MY. Unusual effect of fenflurumine (letter). Br Med J 1969;4:237.
50. Lepkifker E, Dannon PN, Iancu I, Ziv R, Kotler M. Nightmares related to fluoxetine treatment. Clin Neuropharmacol 1995;18:90-4.
51. Chen JL, Brocavich JM, Lin AYF. Psychiatric disturbances associated with ganciclovir therapy. Ann Pharmacother 1992;26:193-5.
52. Bakht FR, Miller LG. Naproxen-associated nightmares. South Med J 1991;84:1271-3.
53. Girdwood RH. Nitrazepam nightmares (letter). Br Med J 1973;13:353.
54. Taylor F. Nitrazepam and the elderly (letter). Br Med J 1973;13:113-4.
55. Solomon K. Thiothixene and bizarre nightmares: an association? J Clin Psychiatry 1983;44:77-8.
56. Devulder J, De Laat M, Dumoulin K, Renson A, Rolly G. Nightmares and hallucinations alter long term intake of tramadol combined with antidepressants. Acta Clin Belg 1996;51:184-6.
57. Solomon K, Bonsack BA. Bizarre nightmares associated with valproic acid: a rare side-effect in the elderly. Clin Gerontol 1993;14:31-6.
58. Kumar KL, Hodges M. Disturbing dreams with long-acting verapamil (letter). N Engl J Med 1988;318:929-30.
59. Koella WP. CNS-related (side-) effects of beta-blockers with special reference to mechanisms of action. Eur J Clin Pharmacol 1985;28(suppl): 55-63.
60. Betts TA, Alford C. Beta-blockers and sleep: a controlled trial. Eur J Clin Pharmacol 1985;28(suppl):65-8.
61. Cove-Smith JR, Kirk CA. CNS-related side-effects with metoprolol and atenolol. Eur J Clin Pharmacol 1985;28(suppl):69-72.
62. Westerlund A. Central nervous system side-effects with hydrophilic and lipophilic beta-blockers. Eur J Clin Pharmacol 1985;28(suppl):73-6.
63. Brismar K, Mogensen L, Wetterberg L. Depressed melatonin secretion in patients with nightmares due to beta-adrenoceptor blocking drugs. Acta Med Scand 1987;221:155-8.
64. Hartmann E. Reserpine: its effect on the sleep-dream cycle in man. Psychopharmacologia 1966;9:242-7.
65. Lin JTY, Ziegler DK. Psychiatric symptoms with initiation of carbidopa-levodopa treatment. Neurology 1976;26:699-700.
66. van Gijn J, Wintzen AR. Depression during L-dopa treatment (letter). Lancet 1969;2:592.
67. Ray I. Side effects from levodopa (letter). Can Med Assoc J 1972;107: 19.
68. O'Brien CP, DiGiacomo JN, Fahn S, Schwarz GA. Mental effects of high-dosage levodopa. Arch Gen Psychiatry 1971;24:61-4.
69. Celesia GG, Barr AN. Psychosis and other psychiatric manifestations of levodopa therapy. Arch Neurol 1970;23:193-200.
70. Benca RM, Quintas J. Sleep and host defenses: a review. Sleep 1997;20: 1027-37.
71. Moldofsky H. Sleep and the immune system. Int J Immunopharmacol 1995;17:649-54.
72. Hall M, Baum A, Buysse DJ, Prigerson HG, Kupfer DJ, Reynolds CF III. Sleep as a mediator of the stress-immune relationship. Psychosom Med 1998;60:48-51.